MedPath

An alternative approach to a frequently used nerve block in patients with a broken hip in the emergency department

Not Applicable
Completed
Conditions
Hip fracture
Musculoskeletal Diseases
Registration Number
ISRCTN74920258
Lead Sponsor
Academic Medical Center
Brief Summary

2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/30770243

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
17
Inclusion Criteria

1. Adult (18 years or older) patients
2. Radiologically confirmed hip fracture

Removed 03/04/2017:
3. Will be treated with a supra-inguinal FICB in the ED

Exclusion Criteria

1. Allergies for local anesthetics
2. Polytrauma patients
3. Not receiving a supra-inguinal FICB

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of participants with a three-point decrease in Numerical Rating Scale (NRS) pain scores is measured prospectively for the FICB group at 30, 60 and 120 minutes after performing the nerve block and retrospectively from patient charts for those in the control group.
Secondary Outcome Measures
NameTimeMethod
<br> 1. Decrease in Numerical Rating Scale (NRS) pain scores for different fracture types is measured at 30, 60 and 120 minutes after administration of the FICB for the FICB group and retrospectively from patient charts for those in the control group<br> 2. Need for additional opioid analgesics is measured by emergency department and anesthesiology staff members, as well as members of the research team at 30, 60 and 120 minutes for the FICB group and retrospectively from patient charts for those in the control group<br> 3. . Occurrence of side effects is measured by emergency department and anesthesiology staff members, as well as members of the research team at 30, 60 and 120 minutes for the FICB group and retrospectively from patient charts for those in the control group<br>
© Copyright 2025. All Rights Reserved by MedPath